214 related articles for article (PubMed ID: 36502795)
1. Aminotransferase Level and the Effects of Dual Antiplatelet in Minor Stroke or Transient Ischemic Attack: A post hoc Analysis of a Randomized Control Trial.
Suo Y; Pan Y; Chen W; Jing J; Yan H; Li H; Liu L; Zhao X; Wang Y; Meng X; Wang Y;
Cerebrovasc Dis; 2023; 52(4):442-450. PubMed ID: 36502795
[TBL] [Abstract][Full Text] [Related]
2. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
[TBL] [Abstract][Full Text] [Related]
3. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor Aspirin vs Clopidogrel Aspirin in
Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Clopidogrel for Prevention of Stroke Based on
Meschia JF; Walton RL; Farrugia LP; Ross OA; Elm JJ; Farrant M; Meurer WJ; Lindblad AS; Barsan W; Ching M; Gentile N; Ross M; Nahab F; Easton JD; Kim AS; Zurita KG; Cucchiara B; Johnston SC
Stroke; 2020 Jul; 51(7):2058-2065. PubMed ID: 32568642
[TBL] [Abstract][Full Text] [Related]
7. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
[TBL] [Abstract][Full Text] [Related]
8. Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With
Lin Y; Wang A; Li J; Lin J; Wang D; Meng X; Ou L; Chen W; Zhao X; Liu L; Wang Y; Wang Y;
Stroke; 2017 Apr; 48(4):998-1004. PubMed ID: 28289237
[TBL] [Abstract][Full Text] [Related]
9. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
[TBL] [Abstract][Full Text] [Related]
10. One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in
Meng X; Wang A; Tian X; Johnston C; Li H; Bath PM; Xu Q; Zhang Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang Y
Neurology; 2024 Feb; 102(3):e207809. PubMed ID: 38181311
[TBL] [Abstract][Full Text] [Related]
11. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
[TBL] [Abstract][Full Text] [Related]
12. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
[TBL] [Abstract][Full Text] [Related]
13. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
[TBL] [Abstract][Full Text] [Related]
14. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
[TBL] [Abstract][Full Text] [Related]
15. Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack.
Wang A; Meng X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang F; Li Y; Liu J; Wang Y;
Ann Neurol; 2022 Mar; 91(3):380-388. PubMed ID: 34951042
[TBL] [Abstract][Full Text] [Related]
16. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
17. CYP2C19 Loss-of-Function is Associated with Increased Risk of Ischemic Stroke after Transient Ischemic Attack in Intracranial Atherosclerotic Disease.
Patel PD; Vimalathas P; Niu X; Shannon CN; Denny JC; Peterson JF; Chitale RV; Fusco MR
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105464. PubMed ID: 33246208
[TBL] [Abstract][Full Text] [Related]
18. Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
Xie X; Jing J; Meng X; Claiborne Johnston S; Bath PM; Li Z; Zhao X; Liu L; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
Stroke; 2023 Sep; 54(9):2241-2250. PubMed ID: 37548009
[TBL] [Abstract][Full Text] [Related]
19. Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke.
Li J; Wang Y; Wang D; Lin J; Wang A; Zhao X; Liu L; Wang C; Wang Y;
Neurology; 2015 Mar; 84(13):1330-6. PubMed ID: 25740863
[TBL] [Abstract][Full Text] [Related]
20. The influence of mean arterial pressure on the efficacy and safety of dual antiplatelet therapy in minor stroke or transient ischemic attack patients.
Ma Y; Liu Y; Xu J; Wang Y; Du F; Wang Y
J Clin Hypertens (Greenwich); 2019 May; 21(5):598-604. PubMed ID: 30957391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
